metoject stungulyf, lausn í áfylltri sprautu 50 mg/ml
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltri sprautu - 50 mg/ml
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 10 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 10 mg
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 12,5 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 12,5 mg
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 15 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 15 mg
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 22,5 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 22,5 mg
smofkabiven innrennslislyf, fleyti
fresenius kabi ab - alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; calcii chloridum; natrii glycerophosphas; magnesii sulfas; kalii chloridum; natrii acetas; zinci sulfas; glucosum; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; piscis oleum omega-3 acidis abundans - innrennslislyf, fleyti
smofkabiven elektrolytfri innrennslislyf, fleyti
fresenius kabi ab - alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; glucosum; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; piscis oleum omega-3 acidis abundans - innrennslislyf, fleyti
smofkabiven perifer innrennslislyf, fleyti
fresenius kabi ab - glucosum; alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; kalii chloridum; zinci sulfas; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; fish oil rich in omega-3 acids; calcii chloridum; lysinum inn; magnesii sulfas; natrii acetas; natrii glycerophosphas - innrennslislyf, fleyti
solu-medrol stungulyfsstofn og leysir, lausn 40 mg
pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 40 mg
airexar spiromax
teva b.v. - salmeterol, flútikasón nef - pulmonary disease, chronic obstructive; asthma - lyf til veikindi öndunarvegi sjúkdómum, - airexar spiromax er ætlað til notkunar hjá fullorðnum 18 ára og eldri. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. langvinn veikindi í lungum (llt)airexar viðeigandi er ætlað til meðferð við sjúklinga með llt, með fev1.